Global Neutropenia Treatment Market By Distribution channel (Retail pharmacies, Hospital pharmacies and Online pharmacies), By Treatment (Colony-stimulating factor, Antibiotics, Antifungals and Antivirals), By Region, Industry Analysis and Forecast, 2020 - 2026
The Global Neutropenia Treatment Market size is expected to reach $18.9 billion by 2026, rising at a market growth of 6.5% CAGR during the forecast period. Neutropenia is an abnormal condition characterized by a critically low level of circulating neutrophils, a type of WBC found in the blood. These cells make up the majority of circulating lymphocytes and help protect the body from infections caused by bacteria, viruses, and other pathogenic organisms. A decrease in the amount of neutrophil in the blood allows a patient to be vulnerable to infection and can also prove fatal. The condition, therefore, requires immediate prophylaxis.
Novel treatments combined with growing cases of chemotherapy-induced neutropenia are one of the primary drivers of market growth. In addition, the novel drug delivery strategy also increases patient convenience, leading to greater adherence to the patient and thereby stimulates the growth of the market. Moreover, since cancer is a known cause of developing neutropenia, increasing cases of chemotherapy for cancer treatment will be a growth driver for the neutropenia treatment market.
One of the new developments to gain momentum in the global neutropenia treatment market is the introduction of small molecules. The development of Plinabulin, a small molecule developed by BeyondSpring Pharmaceuticals with immune-boosting effects, is expected to revolutionize the therapeutic regimen for neutropenia. In addition to the immune-boosting effects, the Phase II studies have revealed much more beneficial anti-cancer effects of this molecule. Currently, there is a high demand for cost-effective drugs for treatment in the neutropenia treatment market. As a result, vendors are focused on the production of small molecules with lower processing costs than biologics.
Based on Distribution channel, the market is segmented into Retail pharmacies, Hospital pharmacies and Online pharmacies. Based on Treatment, the market is segmented into Colony-stimulating factor, Antibiotics, Antifungals and Antivirals. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amgen, Inc., Novartis AG, Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., BeyondSpring, Inc., Spectrum Pharmaceuticals, Inc., Kyowa Kirin Co., Ltd. (Kirin Company), Mylan N.V., Cellerant Therapeutics, Inc., and Partner Therapeutics, Inc.
Strategies deployed in Neutropenia Treatment Market
Jun-2020: Pfizer got FDA approval for NYVEPRIA (pegfilgrastim-apgf), a biosimilar to Neulasta (pegfilgrastim). NYVEPRIA is used for decreasing the incidence of infection, as manifested by febrile neutropenia in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.
Apr-2020: Mylan collaborated with Biocon, a biopharmaceutical company. Together, the companies launched Fulphila, a biosimilar to Neulasta (pegfilgrastim) in Australia and Canada for cancer patients. Fulphila is used for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and reduce the incidence of infections, as manifested by febrile neutropenia. The companies got FDA approval for Fulphila in June, 2018.
Nov-2019: Sandoz, a Novartis division got FDA approval for Ziextenzo (pegfilgrastim-bmez). Ziextenzo has been used to decrease the incidence of febrile neutropenia, one of the most serious side effects of chemotherapy.
Nov-2019: Teva Pharmaceuticals teamed up with Celltrion, Inc., a biopharmaceutical company. Together, the companies announced the launch of TRUXIMA (rituximab-abbs) injection. TRUXIMA is currently indicated for the treatment of adult patients with non-Hodgkin’s Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL).
Jul-2019: Pfizer acquired Array BioPharma Inc., a pharmaceutical company. The acquisition strengthened Pfizer's innovative biopharmaceutical business and category leadership in Oncology expected acceleration of Pfizer’s long-term growth trajectory through new medicines.
Nov-2018: Partner Therapeutics announced that FDA has granted orphan drug designation to Leukine (sargramostim), a yeast-derived recombinant human granulocyte-macrophage colony stimulating factor (rhu-GM-CSF). This drug is used for the treatment of pulmonary alveolar proteinosis (PAP). Leukine works by stimulating the production of white blood cells including neutrophils, monocytes/macrophages and myeloid-derived dendritic cell and promoting their ability to function.
Jul-2018: Cellerant Therapeutics announced that FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation for romyelocel-L (human myeloid progenitor cells) for the prevention of serious bacterial and fungal infections in patients with de novo acute myeloid leukemia (AML) undergoing induction chemotherapy.
Jul-2018: Pfizer announced that it received FDA approval for NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim). This drug expanded the access to critical treatment options for patients with neutropenia.
Feb-2018: Partner Therapeutics signed an agreement with Sanofi. Following the agreement, the former company acquired the global rights for developing, manufacturing, and commercializing Leukine (sargramostim). Leukine is an immuno-stimulant that promotes the growth and activation of a broad range of white blood cells important in activating the body's immune response to fight infection.
Scope of the Study
Market Segmentation:
By Distribution Channel
Novel treatments combined with growing cases of chemotherapy-induced neutropenia are one of the primary drivers of market growth. In addition, the novel drug delivery strategy also increases patient convenience, leading to greater adherence to the patient and thereby stimulates the growth of the market. Moreover, since cancer is a known cause of developing neutropenia, increasing cases of chemotherapy for cancer treatment will be a growth driver for the neutropenia treatment market.
One of the new developments to gain momentum in the global neutropenia treatment market is the introduction of small molecules. The development of Plinabulin, a small molecule developed by BeyondSpring Pharmaceuticals with immune-boosting effects, is expected to revolutionize the therapeutic regimen for neutropenia. In addition to the immune-boosting effects, the Phase II studies have revealed much more beneficial anti-cancer effects of this molecule. Currently, there is a high demand for cost-effective drugs for treatment in the neutropenia treatment market. As a result, vendors are focused on the production of small molecules with lower processing costs than biologics.
Based on Distribution channel, the market is segmented into Retail pharmacies, Hospital pharmacies and Online pharmacies. Based on Treatment, the market is segmented into Colony-stimulating factor, Antibiotics, Antifungals and Antivirals. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amgen, Inc., Novartis AG, Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., BeyondSpring, Inc., Spectrum Pharmaceuticals, Inc., Kyowa Kirin Co., Ltd. (Kirin Company), Mylan N.V., Cellerant Therapeutics, Inc., and Partner Therapeutics, Inc.
Strategies deployed in Neutropenia Treatment Market
Jun-2020: Pfizer got FDA approval for NYVEPRIA (pegfilgrastim-apgf), a biosimilar to Neulasta (pegfilgrastim). NYVEPRIA is used for decreasing the incidence of infection, as manifested by febrile neutropenia in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.
Apr-2020: Mylan collaborated with Biocon, a biopharmaceutical company. Together, the companies launched Fulphila, a biosimilar to Neulasta (pegfilgrastim) in Australia and Canada for cancer patients. Fulphila is used for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and reduce the incidence of infections, as manifested by febrile neutropenia. The companies got FDA approval for Fulphila in June, 2018.
Nov-2019: Sandoz, a Novartis division got FDA approval for Ziextenzo (pegfilgrastim-bmez). Ziextenzo has been used to decrease the incidence of febrile neutropenia, one of the most serious side effects of chemotherapy.
Nov-2019: Teva Pharmaceuticals teamed up with Celltrion, Inc., a biopharmaceutical company. Together, the companies announced the launch of TRUXIMA (rituximab-abbs) injection. TRUXIMA is currently indicated for the treatment of adult patients with non-Hodgkin’s Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL).
Jul-2019: Pfizer acquired Array BioPharma Inc., a pharmaceutical company. The acquisition strengthened Pfizer's innovative biopharmaceutical business and category leadership in Oncology expected acceleration of Pfizer’s long-term growth trajectory through new medicines.
Nov-2018: Partner Therapeutics announced that FDA has granted orphan drug designation to Leukine (sargramostim), a yeast-derived recombinant human granulocyte-macrophage colony stimulating factor (rhu-GM-CSF). This drug is used for the treatment of pulmonary alveolar proteinosis (PAP). Leukine works by stimulating the production of white blood cells including neutrophils, monocytes/macrophages and myeloid-derived dendritic cell and promoting their ability to function.
Jul-2018: Cellerant Therapeutics announced that FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation for romyelocel-L (human myeloid progenitor cells) for the prevention of serious bacterial and fungal infections in patients with de novo acute myeloid leukemia (AML) undergoing induction chemotherapy.
Jul-2018: Pfizer announced that it received FDA approval for NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim). This drug expanded the access to critical treatment options for patients with neutropenia.
Feb-2018: Partner Therapeutics signed an agreement with Sanofi. Following the agreement, the former company acquired the global rights for developing, manufacturing, and commercializing Leukine (sargramostim). Leukine is an immuno-stimulant that promotes the growth and activation of a broad range of white blood cells important in activating the body's immune response to fight infection.
Scope of the Study
Market Segmentation:
By Distribution Channel
- Retail pharmacies
- Hospital pharmacies and
- Online pharmacies
- Colony-stimulating factor
- Antibiotics
- Antifungals and
- Antivirals
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Amgen, Inc.
- Novartis AG
- Pfizer, Inc.
- Teva Pharmaceuticals Industries Ltd.
- BeyondSpring, Inc.
- Spectrum Pharmaceuticals, Inc.
- Kyowa Kirin Co., Ltd. (Kirin Company)
- Mylan N.V.
- Cellerant Therapeutics, Inc.
- Partner Therapeutics, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Neutropenia Treatment Market, by Distribution Channel
1.4.2 Global Neutropenia Treatment Market, by Treatment
1.4.3 Global Neutropenia Treatment Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. GLOBAL NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL
3.1 Global Retail pharmacies Market by Region
3.2 Global Hospital pharmacies Market by Region
3.3 Global Online pharmacies Market by Region
CHAPTER 4. GLOBAL NEUTROPENIA TREATMENT MARKET BY TREATMENT
4.1 Global Colony-stimulating factor Market by Region
4.2 Global Antibiotics Market by Region
4.3 Global Antifungals Market by Region
4.4 Global Antivirals Market by Region
CHAPTER 5. GLOBAL NEUTROPENIA TREATMENT MARKET BY REGION
5.1 North America Neutropenia Treatment Market
5.1.1 North America Neutropenia Treatment Market by Distribution channel
5.1.1.1 North America Retail pharmacies Market by Country
5.1.1.2 North America Hospital pharmacies Market by Country
5.1.1.3 North America Online pharmacies Market by Country
5.1.2 North America Neutropenia Treatment Market by Treatment
5.1.2.1 North America Colony-stimulating factor Market by Country
5.1.2.2 North America Antibiotics Market by Country
5.1.2.3 North America Antifungals Market by Country
5.1.2.4 North America Antivirals Market by Country
5.1.3 North America Neutropenia Treatment Market by Country
5.1.3.1 US Neutropenia Treatment Market
5.1.3.1.1 US Neutropenia Treatment Market by Distribution channel
5.1.3.1.2 US Neutropenia Treatment Market by Treatment
5.1.3.2 Canada Neutropenia Treatment Market
5.1.3.2.1 Canada Neutropenia Treatment Market by Distribution channel
5.1.3.2.2 Canada Neutropenia Treatment Market by Treatment
5.1.3.3 Mexico Neutropenia Treatment Market
5.1.3.3.1 Mexico Neutropenia Treatment Market by Distribution channel
5.1.3.3.2 Mexico Neutropenia Treatment Market by Treatment
5.1.3.4 Rest of North America Neutropenia Treatment Market
5.1.3.4.1 Rest of North America Neutropenia Treatment Market by Distribution channel
5.1.3.4.2 Rest of North America Neutropenia Treatment Market by Treatment
5.2 Europe Neutropenia Treatment Market
5.2.1 Europe Neutropenia Treatment Market by Distribution channel
5.2.1.1 Europe Retail pharmacies Market by Country
5.2.1.2 Europe Hospital pharmacies Market by Country
5.2.1.3 Europe Online pharmacies Market by Country
5.2.2 Europe Neutropenia Treatment Market by Treatment
5.2.2.1 Europe Colony-stimulating factor Market by Country
5.2.2.2 Europe Antibiotics Market by Country
5.2.2.3 Europe Antifungals Market by Country
5.2.2.4 Europe Antivirals Market by Country
5.2.3 Europe Neutropenia Treatment Market by Country
5.2.3.1 Germany Neutropenia Treatment Market
5.2.3.1.1 Germany Neutropenia Treatment Market by Distribution channel
5.2.3.1.2 Germany Neutropenia Treatment Market by Treatment
5.2.3.2 UK Neutropenia Treatment Market
5.2.3.2.1 UK Neutropenia Treatment Market by Distribution channel
5.2.3.2.2 UK Neutropenia Treatment Market by Treatment
5.2.3.3 France Neutropenia Treatment Market
5.2.3.3.1 France Neutropenia Treatment Market by Distribution channel
5.2.3.3.2 France Neutropenia Treatment Market by Treatment
5.2.3.4 Russia Neutropenia Treatment Market
5.2.3.4.1 Russia Neutropenia Treatment Market by Distribution channel
5.2.3.4.2 Russia Neutropenia Treatment Market by Treatment
5.2.3.5 Spain Neutropenia Treatment Market
5.2.3.5.1 Spain Neutropenia Treatment Market by Distribution channel
5.2.3.5.2 Spain Neutropenia Treatment Market by Treatment
5.2.3.6 Italy Neutropenia Treatment Market
5.2.3.6.1 Italy Neutropenia Treatment Market by Distribution channel
5.2.3.6.2 Italy Neutropenia Treatment Market by Treatment
5.2.3.7 Rest of Europe Neutropenia Treatment Market
5.2.3.7.1 Rest of Europe Neutropenia Treatment Market by Distribution channel
5.2.3.7.2 Rest of Europe Neutropenia Treatment Market by Treatment
5.3 Asia Pacific Neutropenia Treatment Market
5.3.1 Asia Pacific Neutropenia Treatment Market by Distribution channel
5.3.1.1 Asia Pacific Retail pharmacies Market by Country
5.3.1.2 Asia Pacific Hospital pharmacies Market by Country
5.3.1.3 Asia Pacific Online pharmacies Market by Country
5.3.2 Asia Pacific Neutropenia Treatment Market by Treatment
5.3.2.1 Asia Pacific Colony-stimulating factor Market by Country
5.3.2.2 Asia Pacific Antibiotics Market by Country
5.3.2.3 Asia Pacific Antifungals Market by Country
5.3.2.4 Asia Pacific Antivirals Market by Country
5.3.3 Asia Pacific Neutropenia Treatment Market by Country
5.3.3.1 China Neutropenia Treatment Market
5.3.3.1.1 China Neutropenia Treatment Market by Distribution channel
5.3.3.1.2 China Neutropenia Treatment Market by Treatment
5.3.3.2 Japan Neutropenia Treatment Market
5.3.3.2.1 Japan Neutropenia Treatment Market by Distribution channel
5.3.3.2.2 Japan Neutropenia Treatment Market by Treatment
5.3.3.3 India Neutropenia Treatment Market
5.3.3.3.1 India Neutropenia Treatment Market by Distribution channel
5.3.3.3.2 India Neutropenia Treatment Market by Treatment
5.3.3.4 South Korea Neutropenia Treatment Market
5.3.3.4.1 South Korea Neutropenia Treatment Market by Distribution channel
5.3.3.4.2 South Korea Neutropenia Treatment Market by Treatment
5.3.3.5 Singapore Neutropenia Treatment Market
5.3.3.5.1 Singapore Neutropenia Treatment Market by Distribution channel
5.3.3.5.2 Singapore Neutropenia Treatment Market by Treatment
5.3.3.6 Malaysia Neutropenia Treatment Market
5.3.3.6.1 Malaysia Neutropenia Treatment Market by Distribution channel
5.3.3.6.2 Malaysia Neutropenia Treatment Market by Treatment
5.3.3.7 Rest of Asia Pacific Neutropenia Treatment Market
5.3.3.7.1 Rest of Asia Pacific Neutropenia Treatment Market by Distribution channel
5.3.3.7.2 Rest of Asia Pacific Neutropenia Treatment Market by Treatment
5.4 LAMEA Neutropenia Treatment Market
5.4.1 LAMEA Neutropenia Treatment Market by Distribution channel
5.4.1.1 LAMEA Retail pharmacies Market by Country
5.4.1.2 LAMEA Hospital pharmacies Market by Country
5.4.1.3 LAMEA Online pharmacies Market by Country
5.4.2 LAMEA Neutropenia Treatment Market by Treatment
5.4.2.1 LAMEA Colony-stimulating factor Market by Country
5.4.2.2 LAMEA Antibiotics Market by Country
5.4.2.3 LAMEA Antifungals Market by Country
5.4.2.4 LAMEA Antivirals Market by Country
5.4.3 LAMEA Neutropenia Treatment Market by Country
5.4.3.1 Brazil Neutropenia Treatment Market
5.4.3.1.1 Brazil Neutropenia Treatment Market by Distribution channel
5.4.3.1.2 Brazil Neutropenia Treatment Market by Treatment
5.4.3.2 Argentina Neutropenia Treatment Market
5.4.3.2.1 Argentina Neutropenia Treatment Market by Distribution channel
5.4.3.2.2 Argentina Neutropenia Treatment Market by Treatment
5.4.3.3 UAE Neutropenia Treatment Market
5.4.3.3.1 UAE Neutropenia Treatment Market by Distribution channel
5.4.3.3.2 UAE Neutropenia Treatment Market by Treatment
5.4.3.4 Saudi Arabia Neutropenia Treatment Market
5.4.3.4.1 Saudi Arabia Neutropenia Treatment Market by Distribution channel
5.4.3.4.2 Saudi Arabia Neutropenia Treatment Market by Treatment
5.4.3.5 South Africa Neutropenia Treatment Market
5.4.3.5.1 South Africa Neutropenia Treatment Market by Distribution channel
5.4.3.5.2 South Africa Neutropenia Treatment Market by Treatment
5.4.3.6 Nigeria Neutropenia Treatment Market
5.4.3.6.1 Nigeria Neutropenia Treatment Market by Distribution channel
5.4.3.6.2 Nigeria Neutropenia Treatment Market by Treatment
5.4.3.7 Rest of LAMEA Neutropenia Treatment Market
5.4.3.7.1 Rest of LAMEA Neutropenia Treatment Market by Distribution channel
5.4.3.7.2 Rest of LAMEA Neutropenia Treatment Market by Treatment
CHAPTER 6. COMPANY PROFILES
6.1 Amgen, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Research & Development Expense
6.2 Novartis AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Recent strategies and developments:
6.2.4.1 Approvals:
6.3 Pfizer, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Recent strategies and developments:
6.3.4.1 Approvals:
6.3.4.2 Acquisition and Mergers:
6.4 Teva Pharmaceutical Industries Ltd.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.5 BeyondSpring, Inc.
6.5.1 Company Overview
6.6 Spectrum Pharmaceuticals, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Research & Development Expenses
6.7 Kyowa Kirin Co., Ltd. (Kirin Company)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Mylan N.V.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Partnerships, Collaborations, and Agreements:
6.9 Cellerant Therapeuticsc, Inc.
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Approvals:
6.1 Partner Therapeutics, Inc.
6.10.1 Company overview
6.10.2 Recent strategies and developments:
6.10.2.1 Partnerships, Collaborations, and Agreements:
6.10.2.2 Approvals:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Neutropenia Treatment Market, by Distribution Channel
1.4.2 Global Neutropenia Treatment Market, by Treatment
1.4.3 Global Neutropenia Treatment Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. GLOBAL NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL
3.1 Global Retail pharmacies Market by Region
3.2 Global Hospital pharmacies Market by Region
3.3 Global Online pharmacies Market by Region
CHAPTER 4. GLOBAL NEUTROPENIA TREATMENT MARKET BY TREATMENT
4.1 Global Colony-stimulating factor Market by Region
4.2 Global Antibiotics Market by Region
4.3 Global Antifungals Market by Region
4.4 Global Antivirals Market by Region
CHAPTER 5. GLOBAL NEUTROPENIA TREATMENT MARKET BY REGION
5.1 North America Neutropenia Treatment Market
5.1.1 North America Neutropenia Treatment Market by Distribution channel
5.1.1.1 North America Retail pharmacies Market by Country
5.1.1.2 North America Hospital pharmacies Market by Country
5.1.1.3 North America Online pharmacies Market by Country
5.1.2 North America Neutropenia Treatment Market by Treatment
5.1.2.1 North America Colony-stimulating factor Market by Country
5.1.2.2 North America Antibiotics Market by Country
5.1.2.3 North America Antifungals Market by Country
5.1.2.4 North America Antivirals Market by Country
5.1.3 North America Neutropenia Treatment Market by Country
5.1.3.1 US Neutropenia Treatment Market
5.1.3.1.1 US Neutropenia Treatment Market by Distribution channel
5.1.3.1.2 US Neutropenia Treatment Market by Treatment
5.1.3.2 Canada Neutropenia Treatment Market
5.1.3.2.1 Canada Neutropenia Treatment Market by Distribution channel
5.1.3.2.2 Canada Neutropenia Treatment Market by Treatment
5.1.3.3 Mexico Neutropenia Treatment Market
5.1.3.3.1 Mexico Neutropenia Treatment Market by Distribution channel
5.1.3.3.2 Mexico Neutropenia Treatment Market by Treatment
5.1.3.4 Rest of North America Neutropenia Treatment Market
5.1.3.4.1 Rest of North America Neutropenia Treatment Market by Distribution channel
5.1.3.4.2 Rest of North America Neutropenia Treatment Market by Treatment
5.2 Europe Neutropenia Treatment Market
5.2.1 Europe Neutropenia Treatment Market by Distribution channel
5.2.1.1 Europe Retail pharmacies Market by Country
5.2.1.2 Europe Hospital pharmacies Market by Country
5.2.1.3 Europe Online pharmacies Market by Country
5.2.2 Europe Neutropenia Treatment Market by Treatment
5.2.2.1 Europe Colony-stimulating factor Market by Country
5.2.2.2 Europe Antibiotics Market by Country
5.2.2.3 Europe Antifungals Market by Country
5.2.2.4 Europe Antivirals Market by Country
5.2.3 Europe Neutropenia Treatment Market by Country
5.2.3.1 Germany Neutropenia Treatment Market
5.2.3.1.1 Germany Neutropenia Treatment Market by Distribution channel
5.2.3.1.2 Germany Neutropenia Treatment Market by Treatment
5.2.3.2 UK Neutropenia Treatment Market
5.2.3.2.1 UK Neutropenia Treatment Market by Distribution channel
5.2.3.2.2 UK Neutropenia Treatment Market by Treatment
5.2.3.3 France Neutropenia Treatment Market
5.2.3.3.1 France Neutropenia Treatment Market by Distribution channel
5.2.3.3.2 France Neutropenia Treatment Market by Treatment
5.2.3.4 Russia Neutropenia Treatment Market
5.2.3.4.1 Russia Neutropenia Treatment Market by Distribution channel
5.2.3.4.2 Russia Neutropenia Treatment Market by Treatment
5.2.3.5 Spain Neutropenia Treatment Market
5.2.3.5.1 Spain Neutropenia Treatment Market by Distribution channel
5.2.3.5.2 Spain Neutropenia Treatment Market by Treatment
5.2.3.6 Italy Neutropenia Treatment Market
5.2.3.6.1 Italy Neutropenia Treatment Market by Distribution channel
5.2.3.6.2 Italy Neutropenia Treatment Market by Treatment
5.2.3.7 Rest of Europe Neutropenia Treatment Market
5.2.3.7.1 Rest of Europe Neutropenia Treatment Market by Distribution channel
5.2.3.7.2 Rest of Europe Neutropenia Treatment Market by Treatment
5.3 Asia Pacific Neutropenia Treatment Market
5.3.1 Asia Pacific Neutropenia Treatment Market by Distribution channel
5.3.1.1 Asia Pacific Retail pharmacies Market by Country
5.3.1.2 Asia Pacific Hospital pharmacies Market by Country
5.3.1.3 Asia Pacific Online pharmacies Market by Country
5.3.2 Asia Pacific Neutropenia Treatment Market by Treatment
5.3.2.1 Asia Pacific Colony-stimulating factor Market by Country
5.3.2.2 Asia Pacific Antibiotics Market by Country
5.3.2.3 Asia Pacific Antifungals Market by Country
5.3.2.4 Asia Pacific Antivirals Market by Country
5.3.3 Asia Pacific Neutropenia Treatment Market by Country
5.3.3.1 China Neutropenia Treatment Market
5.3.3.1.1 China Neutropenia Treatment Market by Distribution channel
5.3.3.1.2 China Neutropenia Treatment Market by Treatment
5.3.3.2 Japan Neutropenia Treatment Market
5.3.3.2.1 Japan Neutropenia Treatment Market by Distribution channel
5.3.3.2.2 Japan Neutropenia Treatment Market by Treatment
5.3.3.3 India Neutropenia Treatment Market
5.3.3.3.1 India Neutropenia Treatment Market by Distribution channel
5.3.3.3.2 India Neutropenia Treatment Market by Treatment
5.3.3.4 South Korea Neutropenia Treatment Market
5.3.3.4.1 South Korea Neutropenia Treatment Market by Distribution channel
5.3.3.4.2 South Korea Neutropenia Treatment Market by Treatment
5.3.3.5 Singapore Neutropenia Treatment Market
5.3.3.5.1 Singapore Neutropenia Treatment Market by Distribution channel
5.3.3.5.2 Singapore Neutropenia Treatment Market by Treatment
5.3.3.6 Malaysia Neutropenia Treatment Market
5.3.3.6.1 Malaysia Neutropenia Treatment Market by Distribution channel
5.3.3.6.2 Malaysia Neutropenia Treatment Market by Treatment
5.3.3.7 Rest of Asia Pacific Neutropenia Treatment Market
5.3.3.7.1 Rest of Asia Pacific Neutropenia Treatment Market by Distribution channel
5.3.3.7.2 Rest of Asia Pacific Neutropenia Treatment Market by Treatment
5.4 LAMEA Neutropenia Treatment Market
5.4.1 LAMEA Neutropenia Treatment Market by Distribution channel
5.4.1.1 LAMEA Retail pharmacies Market by Country
5.4.1.2 LAMEA Hospital pharmacies Market by Country
5.4.1.3 LAMEA Online pharmacies Market by Country
5.4.2 LAMEA Neutropenia Treatment Market by Treatment
5.4.2.1 LAMEA Colony-stimulating factor Market by Country
5.4.2.2 LAMEA Antibiotics Market by Country
5.4.2.3 LAMEA Antifungals Market by Country
5.4.2.4 LAMEA Antivirals Market by Country
5.4.3 LAMEA Neutropenia Treatment Market by Country
5.4.3.1 Brazil Neutropenia Treatment Market
5.4.3.1.1 Brazil Neutropenia Treatment Market by Distribution channel
5.4.3.1.2 Brazil Neutropenia Treatment Market by Treatment
5.4.3.2 Argentina Neutropenia Treatment Market
5.4.3.2.1 Argentina Neutropenia Treatment Market by Distribution channel
5.4.3.2.2 Argentina Neutropenia Treatment Market by Treatment
5.4.3.3 UAE Neutropenia Treatment Market
5.4.3.3.1 UAE Neutropenia Treatment Market by Distribution channel
5.4.3.3.2 UAE Neutropenia Treatment Market by Treatment
5.4.3.4 Saudi Arabia Neutropenia Treatment Market
5.4.3.4.1 Saudi Arabia Neutropenia Treatment Market by Distribution channel
5.4.3.4.2 Saudi Arabia Neutropenia Treatment Market by Treatment
5.4.3.5 South Africa Neutropenia Treatment Market
5.4.3.5.1 South Africa Neutropenia Treatment Market by Distribution channel
5.4.3.5.2 South Africa Neutropenia Treatment Market by Treatment
5.4.3.6 Nigeria Neutropenia Treatment Market
5.4.3.6.1 Nigeria Neutropenia Treatment Market by Distribution channel
5.4.3.6.2 Nigeria Neutropenia Treatment Market by Treatment
5.4.3.7 Rest of LAMEA Neutropenia Treatment Market
5.4.3.7.1 Rest of LAMEA Neutropenia Treatment Market by Distribution channel
5.4.3.7.2 Rest of LAMEA Neutropenia Treatment Market by Treatment
CHAPTER 6. COMPANY PROFILES
6.1 Amgen, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Research & Development Expense
6.2 Novartis AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Recent strategies and developments:
6.2.4.1 Approvals:
6.3 Pfizer, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Recent strategies and developments:
6.3.4.1 Approvals:
6.3.4.2 Acquisition and Mergers:
6.4 Teva Pharmaceutical Industries Ltd.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.5 BeyondSpring, Inc.
6.5.1 Company Overview
6.6 Spectrum Pharmaceuticals, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Research & Development Expenses
6.7 Kyowa Kirin Co., Ltd. (Kirin Company)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Mylan N.V.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Partnerships, Collaborations, and Agreements:
6.9 Cellerant Therapeuticsc, Inc.
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Approvals:
6.1 Partner Therapeutics, Inc.
6.10.1 Company overview
6.10.2 Recent strategies and developments:
6.10.2.1 Partnerships, Collaborations, and Agreements:
6.10.2.2 Approvals:
LIST OF TABLES
TABLE 1 GLOBAL NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 2 GLOBAL NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 3 GLOBAL NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 4 GLOBAL NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 5 GLOBAL RETAIL PHARMACIES MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 6 GLOBAL RETAIL PHARMACIES MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 7 GLOBAL HOSPITAL PHARMACIES MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 8 GLOBAL HOSPITAL PHARMACIES MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 9 GLOBAL ONLINE PHARMACIES MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 10 GLOBAL ONLINE PHARMACIES MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 11 GLOBAL NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 12 GLOBAL NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 13 GLOBAL COLONY-STIMULATING FACTOR MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 14 GLOBAL COLONY-STIMULATING FACTOR MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 15 GLOBAL ANTIBIOTICS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 16 GLOBAL ANTIBIOTICS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 17 GLOBAL ANTIFUNGALS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 18 GLOBAL ANTIFUNGALS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 19 GLOBAL ANTIVIRALS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 20 GLOBAL ANTIVIRALS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 21 GLOBAL NEUTROPENIA TREATMENT MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 22 GLOBAL NEUTROPENIA TREATMENT MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 23 NORTH AMERICA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 24 NORTH AMERICA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 25 NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 26 NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 27 NORTH AMERICA RETAIL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 NORTH AMERICA RETAIL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 NORTH AMERICA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 NORTH AMERICA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 NORTH AMERICA ONLINE PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 NORTH AMERICA ONLINE PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 34 NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 35 NORTH AMERICA COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 36 NORTH AMERICA COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 37 NORTH AMERICA ANTIBIOTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 38 NORTH AMERICA ANTIBIOTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 39 NORTH AMERICA ANTIFUNGALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 40 NORTH AMERICA ANTIFUNGALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 41 NORTH AMERICA ANTIVIRALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 42 NORTH AMERICA ANTIVIRALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 43 NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 44 NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 45 US NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 46 US NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 47 US NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 48 US NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 49 US NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 50 US NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 51 CANADA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 52 CANADA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 53 CANADA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 54 CANADA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 55 CANADA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 56 CANADA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 57 MEXICO NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 58 MEXICO NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 59 MEXICO NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 60 MEXICO NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 61 MEXICO NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 62 MEXICO NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 63 REST OF NORTH AMERICA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 64 REST OF NORTH AMERICA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 65 REST OF NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 66 REST OF NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 67 REST OF NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 68 REST OF NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 69 EUROPE NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 70 EUROPE NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 71 EUROPE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 72 EUROPE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 73 EUROPE RETAIL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 74 EUROPE RETAIL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 75 EUROPE HOSPITAL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 76 EUROPE HOSPITAL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 77 EUROPE ONLINE PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 78 EUROPE ONLINE PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 79 EUROPE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 80 EUROPE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 81 EUROPE COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 82 EUROPE COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 83 EUROPE ANTIBIOTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 84 EUROPE ANTIBIOTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 85 EUROPE ANTIFUNGALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 86 EUROPE ANTIFUNGALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 87 EUROPE ANTIVIRALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 88 EUROPE ANTIVIRALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 89 EUROPE NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 90 EUROPE NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 91 GERMANY NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 92 GERMANY NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 93 GERMANY NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 94 GERMANY NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 95 GERMANY NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 96 GERMANY NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 97 UK NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 98 UK NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 99 UK NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 100 UK NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 101 UK NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 102 UK NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 103 FRANCE NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 104 FRANCE NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 105 FRANCE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 106 FRANCE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 107 FRANCE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 – 2019, USD MILLION
TABLE 108 FRANCE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 109 RUSSIA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 110 RUSSIA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 111 RUSSIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 112 RUSSIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 113 RUSSIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 114 RUSSIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 115 SPAIN NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 116 SPAIN NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 117 SPAIN NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 118 SPAIN NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 119 SPAIN NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 120 SPAIN NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 121 ITALY NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 122 ITALY NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 123 ITALY NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 124 ITALY NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 125 ITALY NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 126 REST OF EUROPE NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 127 REST OF EUROPE NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 128 REST OF EUROPE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 129 REST OF EUROPE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 130 REST OF EUROPE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 131 REST OF EUROPE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 132 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 133 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 134 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 135 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 136 ASIA PACIFIC RETAIL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 137 ASIA PACIFIC RETAIL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 138 ASIA PACIFIC HOSPITAL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 139 ASIA PACIFIC HOSPITAL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 140 ASIA PACIFIC ONLINE PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 141 ASIA PACIFIC ONLINE PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 142 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 143 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 144 ASIA PACIFIC COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 145 ASIA PACIFIC COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 146 ASIA PACIFIC ANTIBIOTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 147 ASIA PACIFIC ANTIBIOTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 148 ASIA PACIFIC ANTIFUNGALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 149 ASIA PACIFIC ANTIFUNGALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 150 ASIA PACIFIC ANTIVIRALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 151 ASIA PACIFIC ANTIVIRALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 152 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 153 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 154 CHINA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 155 CHINA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 156 CHINA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 157 CHINA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 158 CHINA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 159 CHINA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 160 JAPAN NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 161 JAPAN NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 162 JAPAN NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 163 JAPAN NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 164 JAPAN NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 165 INDIA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 166 INDIA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 167 INDIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 168 INDIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 169 INDIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 170 INDIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 171 SOUTH KOREA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 172 SOUTH KOREA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 173 SOUTH KOREA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 174 SOUTH KOREA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 175 SOUTH KOREA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 176 SOUTH KOREA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 177 SINGAPORE NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 178 SINGAPORE NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 179 SINGAPORE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 180 SINGAPORE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 181 SINGAPORE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 182 SINGAPORE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 183 MALAYSIA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 184 MALAYSIA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 185 MALAYSIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 186 MALAYSIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 187 MALAYSIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 188 MALAYSIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 189 REST OF ASIA PACIFIC NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 190 REST OF ASIA PACIFIC NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 191 REST OF ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 192 REST OF ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 193 REST OF ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 194 REST OF ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 195 LAMEA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 196 LAMEA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 197 LAMEA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 198 LAMEA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 199 LAMEA RETAIL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 200 LAMEA RETAIL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 201 LAMEA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 202 LAMEA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 203 LAMEA ONLINE PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 204 LAMEA ONLINE PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 205 LAMEA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 206 LAMEA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 207 LAMEA COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 208 LAMEA COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 209 LAMEA ANTIBIOTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 210 LAMEA ANTIBIOTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 211 LAMEA ANTIFUNGALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 212 LAMEA ANTIFUNGALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 213 LAMEA ANTIVIRALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 214 LAMEA ANTIVIRALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 215 LAMEA NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 216 LAMEA NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 217 BRAZIL NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 218 BRAZIL NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 219 BRAZIL NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 220 BRAZIL NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 221 BRAZIL NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 222 BRAZIL NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 223 ARGENTINA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 224 ARGENTINA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 225 ARGENTINA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 226 ARGENTINA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 227 ARGENTINA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 228 ARGENTINA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 229 UAE NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 230 UAE NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 231 UAE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 232 UAE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 233 UAE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 234 UAE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 235 SAUDI ARABIA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 236 SAUDI ARABIA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 237 SAUDI ARABIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 238 SAUDI ARABIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 239 SAUDI ARABIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 240 SAUDI ARABIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 241 SOUTH AFRICA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 242 SOUTH AFRICA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 243 SOUTH AFRICA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 244 SOUTH AFRICA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 245 SOUTH AFRICA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 246 SOUTH AFRICA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 247 NIGERIA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 248 NIGERIA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 249 NIGERIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 250 NIGERIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 251 NIGERIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 252 NIGERIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 253 REST OF LAMEA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 254 REST OF LAMEA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 255 REST OF LAMEA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 256 REST OF LAMEA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 257 REST OF LAMEA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 258 REST OF LAMEA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 259 KEY INFORMATION – AMGEN, INC.
TABLE 260 KEY INFORMATION – NOVARTIS AG
TABLE 261 KEY INFORMATION – PFIZER, INC.
TABLE 262 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 263 KEY INFORMATION – BEYONDSPRING, INC.
TABLE 264 KEY INFORMATION – SPECTRUM PHARMACEUTICALS, INC.
TABLE 265 KEY INFORMATION – KYOWA KIRIN CO., LTD.
TABLE 266 KEY INFORMATION – MYLAN N.V.
TABLE 267 KEY INFORMATION – CELLERANT THERAPEUTICS, INC.
TABLE 268 KEY INFORMATION – PARTNER THERAPEUTICS, INC.
TABLE 1 GLOBAL NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 2 GLOBAL NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 3 GLOBAL NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 4 GLOBAL NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 5 GLOBAL RETAIL PHARMACIES MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 6 GLOBAL RETAIL PHARMACIES MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 7 GLOBAL HOSPITAL PHARMACIES MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 8 GLOBAL HOSPITAL PHARMACIES MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 9 GLOBAL ONLINE PHARMACIES MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 10 GLOBAL ONLINE PHARMACIES MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 11 GLOBAL NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 12 GLOBAL NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 13 GLOBAL COLONY-STIMULATING FACTOR MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 14 GLOBAL COLONY-STIMULATING FACTOR MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 15 GLOBAL ANTIBIOTICS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 16 GLOBAL ANTIBIOTICS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 17 GLOBAL ANTIFUNGALS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 18 GLOBAL ANTIFUNGALS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 19 GLOBAL ANTIVIRALS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 20 GLOBAL ANTIVIRALS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 21 GLOBAL NEUTROPENIA TREATMENT MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 22 GLOBAL NEUTROPENIA TREATMENT MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 23 NORTH AMERICA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 24 NORTH AMERICA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 25 NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 26 NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 27 NORTH AMERICA RETAIL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 NORTH AMERICA RETAIL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 NORTH AMERICA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 NORTH AMERICA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 NORTH AMERICA ONLINE PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 NORTH AMERICA ONLINE PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 34 NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 35 NORTH AMERICA COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 36 NORTH AMERICA COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 37 NORTH AMERICA ANTIBIOTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 38 NORTH AMERICA ANTIBIOTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 39 NORTH AMERICA ANTIFUNGALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 40 NORTH AMERICA ANTIFUNGALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 41 NORTH AMERICA ANTIVIRALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 42 NORTH AMERICA ANTIVIRALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 43 NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 44 NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 45 US NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 46 US NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 47 US NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 48 US NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 49 US NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 50 US NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 51 CANADA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 52 CANADA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 53 CANADA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 54 CANADA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 55 CANADA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 56 CANADA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 57 MEXICO NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 58 MEXICO NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 59 MEXICO NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 60 MEXICO NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 61 MEXICO NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 62 MEXICO NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 63 REST OF NORTH AMERICA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 64 REST OF NORTH AMERICA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 65 REST OF NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 66 REST OF NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 67 REST OF NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 68 REST OF NORTH AMERICA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 69 EUROPE NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 70 EUROPE NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 71 EUROPE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 72 EUROPE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 73 EUROPE RETAIL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 74 EUROPE RETAIL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 75 EUROPE HOSPITAL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 76 EUROPE HOSPITAL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 77 EUROPE ONLINE PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 78 EUROPE ONLINE PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 79 EUROPE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 80 EUROPE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 81 EUROPE COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 82 EUROPE COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 83 EUROPE ANTIBIOTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 84 EUROPE ANTIBIOTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 85 EUROPE ANTIFUNGALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 86 EUROPE ANTIFUNGALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 87 EUROPE ANTIVIRALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 88 EUROPE ANTIVIRALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 89 EUROPE NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 90 EUROPE NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 91 GERMANY NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 92 GERMANY NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 93 GERMANY NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 94 GERMANY NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 95 GERMANY NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 96 GERMANY NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 97 UK NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 98 UK NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 99 UK NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 100 UK NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 101 UK NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 102 UK NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 103 FRANCE NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 104 FRANCE NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 105 FRANCE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 106 FRANCE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 107 FRANCE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 – 2019, USD MILLION
TABLE 108 FRANCE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 109 RUSSIA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 110 RUSSIA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 111 RUSSIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 112 RUSSIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 113 RUSSIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 114 RUSSIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 115 SPAIN NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 116 SPAIN NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 117 SPAIN NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 118 SPAIN NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 119 SPAIN NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 120 SPAIN NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 121 ITALY NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 122 ITALY NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 123 ITALY NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 124 ITALY NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 125 ITALY NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 126 REST OF EUROPE NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 127 REST OF EUROPE NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 128 REST OF EUROPE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 129 REST OF EUROPE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 130 REST OF EUROPE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 131 REST OF EUROPE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 132 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 133 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 134 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 135 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 136 ASIA PACIFIC RETAIL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 137 ASIA PACIFIC RETAIL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 138 ASIA PACIFIC HOSPITAL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 139 ASIA PACIFIC HOSPITAL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 140 ASIA PACIFIC ONLINE PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 141 ASIA PACIFIC ONLINE PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 142 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 143 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 144 ASIA PACIFIC COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 145 ASIA PACIFIC COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 146 ASIA PACIFIC ANTIBIOTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 147 ASIA PACIFIC ANTIBIOTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 148 ASIA PACIFIC ANTIFUNGALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 149 ASIA PACIFIC ANTIFUNGALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 150 ASIA PACIFIC ANTIVIRALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 151 ASIA PACIFIC ANTIVIRALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 152 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 153 ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 154 CHINA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 155 CHINA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 156 CHINA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 157 CHINA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 158 CHINA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 159 CHINA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 160 JAPAN NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 161 JAPAN NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 162 JAPAN NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 163 JAPAN NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 164 JAPAN NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 165 INDIA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 166 INDIA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 167 INDIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 168 INDIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 169 INDIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 170 INDIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 171 SOUTH KOREA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 172 SOUTH KOREA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 173 SOUTH KOREA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 174 SOUTH KOREA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 175 SOUTH KOREA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 176 SOUTH KOREA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 177 SINGAPORE NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 178 SINGAPORE NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 179 SINGAPORE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 180 SINGAPORE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 181 SINGAPORE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 182 SINGAPORE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 183 MALAYSIA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 184 MALAYSIA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 185 MALAYSIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 186 MALAYSIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 187 MALAYSIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 188 MALAYSIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 189 REST OF ASIA PACIFIC NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 190 REST OF ASIA PACIFIC NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 191 REST OF ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 192 REST OF ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 193 REST OF ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 194 REST OF ASIA PACIFIC NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 195 LAMEA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 196 LAMEA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 197 LAMEA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 198 LAMEA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 199 LAMEA RETAIL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 200 LAMEA RETAIL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 201 LAMEA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 202 LAMEA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 203 LAMEA ONLINE PHARMACIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 204 LAMEA ONLINE PHARMACIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 205 LAMEA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 206 LAMEA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 207 LAMEA COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 208 LAMEA COLONY-STIMULATING FACTOR MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 209 LAMEA ANTIBIOTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 210 LAMEA ANTIBIOTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 211 LAMEA ANTIFUNGALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 212 LAMEA ANTIFUNGALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 213 LAMEA ANTIVIRALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 214 LAMEA ANTIVIRALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 215 LAMEA NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 216 LAMEA NEUTROPENIA TREATMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 217 BRAZIL NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 218 BRAZIL NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 219 BRAZIL NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 220 BRAZIL NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 221 BRAZIL NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 222 BRAZIL NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 223 ARGENTINA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 224 ARGENTINA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 225 ARGENTINA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 226 ARGENTINA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 227 ARGENTINA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 228 ARGENTINA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 229 UAE NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 230 UAE NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 231 UAE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 232 UAE NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 233 UAE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 234 UAE NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 235 SAUDI ARABIA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 236 SAUDI ARABIA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 237 SAUDI ARABIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 238 SAUDI ARABIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 239 SAUDI ARABIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 240 SAUDI ARABIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 241 SOUTH AFRICA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 242 SOUTH AFRICA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 243 SOUTH AFRICA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 244 SOUTH AFRICA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 245 SOUTH AFRICA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 246 SOUTH AFRICA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 247 NIGERIA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 248 NIGERIA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 249 NIGERIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 250 NIGERIA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 251 NIGERIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 252 NIGERIA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 253 REST OF LAMEA NEUTROPENIA TREATMENT MARKET, 2016 - 2019, USD MILLION
TABLE 254 REST OF LAMEA NEUTROPENIA TREATMENT MARKET, 2020 - 2026, USD MILLION
TABLE 255 REST OF LAMEA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2016 - 2019, USD MILLION
TABLE 256 REST OF LAMEA NEUTROPENIA TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2020 - 2026, USD MILLION
TABLE 257 REST OF LAMEA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 258 REST OF LAMEA NEUTROPENIA TREATMENT MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 259 KEY INFORMATION – AMGEN, INC.
TABLE 260 KEY INFORMATION – NOVARTIS AG
TABLE 261 KEY INFORMATION – PFIZER, INC.
TABLE 262 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 263 KEY INFORMATION – BEYONDSPRING, INC.
TABLE 264 KEY INFORMATION – SPECTRUM PHARMACEUTICALS, INC.
TABLE 265 KEY INFORMATION – KYOWA KIRIN CO., LTD.
TABLE 266 KEY INFORMATION – MYLAN N.V.
TABLE 267 KEY INFORMATION – CELLERANT THERAPEUTICS, INC.
TABLE 268 KEY INFORMATION – PARTNER THERAPEUTICS, INC.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
